A carregar...
Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis
Two new drugs—bedaquiline and delamanid—have recently been approved by stringent regulatory authorities to treat multidrug-resistant tuberculosis (TB) and recommended by the World Health Organization for use under defined programmatic conditions. Introducing the medications in TB programs worldwide...
Na minha lista:
| Publicado no: | Emerg Infect Dis |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Centers for Disease Control and Prevention
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4766879/ https://ncbi.nlm.nih.gov/pubmed/26885674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid2203.151430 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|